|

G-CSF (Filgrastim) Clinical Trials

2 actively recruiting trials

Also known as: Neupomax, Tevagrastim, Zarzio

Pipeline

Phase 2: 2

Top Sponsors

  • Yaqrit Ltd1
  • Blokhin's Russian Cancer Research Center1

Indications

  • Alcoholic Hepatitis1
  • Liver Cirrhosis, Alcoholic1
  • Acute on Chronic Liver Failure1
  • Liver Disease1
  • Germ Cell Cancer Metastatic1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.